The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D; Oncogene, 2007, vol. 26, issue 49, p 7058, ISSN 09509232. ISBN 09509232.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef